← all drugs

Ifosfamide Injection

in shortage · Oncology · Snapshot: 2026-08-25

Day 74

of this shortage, counting from the FDA's first posting on 06/12/2026

Manufacturers listed
Hikma Pharmaceuticals USA, Inc., Fresenius Kabi USA, LLC, Baxter Healthcare
Reported reason(s)
Demand increase for the drug; Requirements related to complying with good manufacturing practices
Machine-readable
JSON for this drug

Presentations (7)

PresentationCompanyAvailabilityUpdated
Ifosfamide, Injection, 50 mg/1 mL (NDC 0143-9531-01)Hikma Pharmaceuticals USA, Inc. Unavailable 08/13/2026
Ifosfamide, Injection, 1 g (NDC 63323-142-10)Fresenius Kabi USA, LLC Unavailable 08/04/2026
Ifosfamide, Injection, 50 mg/1 mL (NDC 0143-9530-01)Hikma Pharmaceuticals USA, Inc. Unavailable 08/13/2026
IFEX, Injection, 3 g/60 mL (NDC 0338-3993-01)Baxter Healthcare Unavailable 08/17/2026
Ifosfamide, Injection, 1 g/20 mL (NDC 10019-925-01)Baxter Healthcare Unavailable 08/17/2026
IFEX, Injection, 1 g/20 mL (NDC 0338-3991-01)Baxter Healthcare Unavailable 08/17/2026
Ifosfamide, Injection, 3 g/60 mL (NDC 10019-926-02)Baxter Healthcare Unavailable 08/17/2026

History

Daily change tracking began 2026-08-25 (index founding). Status flips and availability changes will accumulate here.

Not medical advice. ShortSupply republishes the FDA's drug-shortage data with history added. Talk to your pharmacist or prescriber about your situation — never change medication based on this site.